ON-ROAD DRIVING PERFORMANCE THE MORNING AFTER BEDTIME SELTOREXANT IN MAJOR DEPRESSIVE DISORDER AND HEALTHY ELDERLY

被引:0
|
作者
Devineni, Damayanthi [1 ]
Li, Lingjue [2 ]
Zhou, Xianhuang [1 ]
Pinter, Christine [2 ]
Flossbach, Yanina [3 ]
Pandina, Gahan [2 ]
Buntinx, Erik [4 ]
机构
[1] Janssen Res & Dev, Raritan, NJ USA
[2] Janssen Res & Dev, Titusville, NJ USA
[3] Janssen Res & Dev, Allschwil, Switzerland
[4] Anima Res Ctr, Alken, Belgium
关键词
D O I
10.1093/sleep/zsae067.0469
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
0469
引用
收藏
页数:1
相关论文
共 37 条
  • [21] CPT performance in major depressive disorder before and after treatment with imipramine or fluvoxamine
    Koetsier, GC
    Volkers, AC
    Tulen, JHM
    Passchier, J
    van den Broek, WW
    Bruijn, JA
    JOURNAL OF PSYCHIATRIC RESEARCH, 2002, 36 (06) : 391 - 397
  • [22] Comparison of cognitive performance in bipolar disorder, major depressive disorder, unaffected first-degree relatives, and healthy controls
    Bo, Qijing
    Dong, Fang
    Li, Xianbin
    Li, Feng
    Li, Peng
    Yu, Haiting
    He, Fan
    Zhang, Guofu
    Wang, Zhimin
    Ma, Xin
    Wang, Chuanyue
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2019, 73 (02) : 70 - 76
  • [23] NEUROCOGNITIVE PERFORMANCE IN ADULTS WITH MAJOR DEPRESSIVE DISORDER AFTER REPEATED PARTIAL SLEEP DEPRIVATION
    Arnedt, J.
    Swanson, L.
    Bertram, H.
    Mooney, A.
    Dopp, R.
    Hoffmann, R. F.
    Armitage, R.
    SLEEP, 2012, 35 : A326 - A326
  • [24] Circadian preference and sleep quality in healthy controls and psychiatric inpatients with major depressive disorder - An actigraphy study incorporating morning and evening mood assessments
    Cabanel, Nicole
    Schmidt, Anne-Marthe
    Fockenberg, Stanislava
    Brueckmann, Konstantin
    Mueller, Matthias J.
    Kundermann, Bernd
    Haag, Anja
    CHRONOBIOLOGY INTERNATIONAL, 2022, 39 (02) : 249 - 260
  • [25] Effects of cortisol on hippocampal subfields volumes and memory performance in healthy control subjects and patients with major depressive disorder
    Travis, Scott G.
    Coupland, Nicholas J.
    Hegadoren, K.
    Silverstone, Peter H.
    Huang, Yushan
    Carter, Rawle
    Fujiwara, Esther
    Seres, Peter
    Malykhin, Nikolai V.
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 201 : 34 - 41
  • [26] Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers
    Jennifer W. Evans
    Morgan C. Graves
    Allison C. Nugent
    Carlos A. Zarate
    Scientific Reports, 14
  • [27] URINARY NEOPTERINE LEVELS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: ALTERATIONS AFTER TREATMENT WITH PAROXETINE AND COMPARISON WITH HEALTHY CONTROLS
    Taymur, Ibrahim
    Ozdel, Kadir
    Ozen, Nurper Erberk
    Gungor, Buket Belkiz
    Atmaca, Murad
    PSYCHIATRIA DANUBINA, 2015, 27 (01) : 25 - 30
  • [28] Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers
    Evans, Jennifer W.
    Graves, Morgan C.
    Nugent, Allison C.
    Zarate, Carlos A.
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [29] THE EFFECT OF THE OCCURRENCE OF REM-SLEEP DURING MORNING NAPS ON MOOD AFTER SLEEP-DEPRIVATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    RIEMANN, D
    WIEGAND, M
    ZULLEY, J
    LAUER, C
    SCHREIBER, W
    BERGER, M
    SLEEP 88, 1989, : 230 - 232
  • [30] Association of brain white matter microstructure with cognitive performance in major depressive disorder and healthy controls: a diffusion-tensor imaging study
    Meinert, Susanne
    Nowack, Nico
    Grotegerd, Dominik
    Repple, Jonathan
    Winter, Nils R.
    Abheiden, Isabel
    Enneking, Verena
    Lemke, Hannah
    Waltemate, Lena
    Stein, Frederike
    Brosch, Katharina
    Schmitt, Simon
    Meller, Tina
    Pfarr, Julia-Katharina
    Ringwald, Kai
    Steinstrater, Olaf
    Gruber, Marius
    Nenadie, Igor
    Krug, Axel
    Leehr, Elisabeth J.
    Hahn, Tim
    Thiel, Katharina
    Dohm, Katharina
    Winter, Alexandra
    Opel, Nils
    Schubotz, Ricarda, I
    Kircher, Tilo
    Dannlowski, Udo
    MOLECULAR PSYCHIATRY, 2022, 27 (02) : 1103 - 1110